Novel Azepinoindole Compounds as 5‑HT2A Agonists for Treating Neuropsychiatric and Neurodegenerative Disorders
- ACS Med Chem Lett. 2025 Oct 20;16(11):2181-2182. doi: 10.1021/acsmedchemlett.5c00613.
Affiliations
- 1. Arclin USA LLC, 1150 Sanctuary Parkway, Suite 100, Alpharetta, Georgia 30009, United States.
PMID: 41256984
DOI: 10.1021/acsmedchemlett.5c00613
Abstract
Provided herein are novel azepinoindole compounds as 5-HT2A agonists, pharmaceutical compositions, use of such compounds in treating neuropsychiatric and neurodegenerative disorders, and processes for preparing such compounds.
Products
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: 5-HT ReceptorResearch Areas: Neurological Disease